The development of multicancer early detection tests has surged in recent years. When evaluating such tests, it will be important to maintain a high bar for concluding that there is evidence of benefit.
No takes yet. Share an insight, caveat, or question.
Hilary A. Robbins (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: